The Ohio House of Representatives officially voted to concur on Senate amendments to HB 341 after nearly a year of deliberation between both the House and Senate. HB 341, sponsored by Representative Tim Ginter (R-Salem), seeks to expand the portfolio of medications that pharmacists can administer to patients. The legislation now heads to Governor DeWine for his signature.
In the 131st General Assembly, OPA was successful in pushing to enact legislation that allowed pharmacists to administer certain types of long-acting injectable medications, which include opioid antagonists for drug addiction or alcohol dependence; antipsychotic drugs; hydroxyprogesterone for pregnant women; medroxyprogesterone for non-pregnant women; and cobalamin (including cyanocobalamin or hydroxycobalamin).
HB 341 would expand the law beyond opioid antagonists, and allow pharmacists to administer any drug used for drug addiction or alcohol dependence.
OPA Independent SIG Chair Mimi Hart and OPA government affairs director Antonio Ciaccia both provided testimony in support of the bill during its committee process
OPA thanks Representative Ginter for his tireless advocacy on the bill, and we thank Senate President Larry Obhof and Speaker of the House Bob Cupp for advancing the measure to Governor DeWine.